U.S. government health regulators will allow GlaxoSmithKline to continue selling a controversial diabetes pill but will restrict access to the once-blockbuster drug because of heart attack risks.
Diabetes pill Avandia to be severely restricted
Posted in Health by healthnutter 609 days ago« previous1 next »
Advertisement: Your Advert Here